Integrating Biomedical Engineering And Pharmaceutical Sciences For Advanced Healthcare Innovation-An Updated Review

Authors

  • Mesfer Zaid Hathal Alkhamis
  • Fahad Mohmmed Al Thafir
  • Mohammed Abdullah Alskhabrah
  • Mohammed Razqan Matar Almutairi
  • Mohammed Fahad Bin Zayid
  • Sultan Ghusayn Aldawsari
  • Mohammed Mahdi Mufarrah Al-Kubra
  • Mohammed Abdullah Al Suliman
  • Mishal Rashid Al Juma
  • Nasser Saeed Alwuhayyid
  • Zakaria Mohammed Al Muhaymid
  • Ibrahim Abdullahi Alnughaythir
  • Shaluq Meshal Shaluq Alshammari
  • Abdulrahman Abdullah I Alnughaythir

DOI:

https://doi.org/10.70082/4pjsn355

Abstract

Background: The integration of biomedical engineering and pharmaceutical sciences has become a driving force behind modern healthcare innovation. The article highlights how advancements in imaging, biosensors, biochips, and drug‑delivery systems collectively reshape clinical practice and patient outcomes.

Aim: The primary objective was to review current biomedical engineering technologies, their mechanisms, and their contributions to diagnostics, monitoring, and therapeutic delivery across healthcare systems.

Methods: The article synthesizes evidence from major biomedical domains, including medical imaging, biosensor technologies (wearable and non‑wearable), microarray and microfluidic biochips, and engineered drug‑delivery platforms. It draws on documented applications, technological principles, and clinical outcomes to construct an updated interdisciplinary overview.

Results: Biomedical engineering innovations have significantly enhanced diagnostic precision, expanded real‑time physiological monitoring, and enabled targeted therapeutic delivery. AI‑assisted imaging markedly accelerates analysis and improves diagnostic accuracy, while nanoscale biosensors achieve high sensitivity for clinical and environmental detection.  Wearable and non‑wearable sensors strengthen continuous care, chronic disease management, and remote monitoring.  Biochip platforms support high‑throughput genetic, proteomic, and cellular analyses, advancing personalized medicine and drug discovery.  Nanotechnology‑enabled drug‑delivery systems improve targeting, bioavailability, and controlled release.

Conclusion: The convergence of engineering and biomedical sciences has transformed healthcare into a more precise, data‑driven, and patient‑centered system. Continued development of intelligent imaging systems, nanoscale biosensors, microfluidic biochips, and engineered drug‑delivery platforms will accelerate personalized and predictive medicine. These technologies collectively advance early diagnosis, optimized therapy, and continuous monitoring, ultimately improving patient outcomes and reducing healthcare burdens.

Downloads

Published

2024-04-10

Issue

Section

Articles

How to Cite

Integrating Biomedical Engineering And Pharmaceutical Sciences For Advanced Healthcare Innovation-An Updated Review. (2024). The Review of Diabetic Studies , 358-375. https://doi.org/10.70082/4pjsn355